These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 9931087)

  • 1. Renal characteristics and effect of angiotensin suppression in oral contraceptive users.
    Ribstein J; Halimi JM; du Cailar G; Mimran A
    Hypertension; 1999 Jan; 33(1):90-5. PubMed ID: 9931087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of oral contraceptives on the renin angiotensin system and renal function.
    Kang AK; Duncan JA; Cattran DC; Floras JS; Lai V; Scholey JW; Miller JA
    Am J Physiol Regul Integr Comp Physiol; 2001 Mar; 280(3):R807-13. PubMed ID: 11171661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
    Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blunted renal responses to angiotensin II infusion in lifetime captopril-treated spontaneously hypertensive rats.
    Wu JN; Tsai SY; Hsieh WY
    Chin J Physiol; 2001 Jun; 44(2):59-65. PubMed ID: 11530945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats.
    Bolterman RJ; Manriquez MC; Ortiz Ruiz MC; Juncos LA; Romero JC
    Hypertension; 2005 Oct; 46(4):943-7. PubMed ID: 16087785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraceptives, angiotensin-dependent renal vasoconstriction, and risk of diabetic nephropathy.
    Ahmed SB; Hovind P; Parving HH; Rossing P; Price DA; Laffel LM; Lansang MC; Stevanovic R; Fisher ND; Hollenberg NK
    Diabetes Care; 2005 Aug; 28(8):1988-94. PubMed ID: 16043743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of converting enzyme inhibition on split renal function in renovascular hypertension.
    Miyamori I; Yasuhara S; Takeda Y; Koshida H; Ikeda M; Nagai K; Okamoto H; Morise T; Takeda R; Aburano T
    Hypertension; 1986 May; 8(5):415-21. PubMed ID: 3009326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of captopril on renal hemodynamics in hypertensive patients.
    Duchin KL; Willard DA
    J Clin Pharmacol; 1984; 24(8-9):351-9. PubMed ID: 6384279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced activity of the kallikrein-kinin system predominates over renin-angiotensin system overactivity in all conditions of sodium balance in essential hypertensives and family-related hypertension.
    Sànchez R; Nolly H; Giannone C; Baglivo HP; Ramírez AJ
    J Hypertens; 2003 Feb; 21(2):411-7. PubMed ID: 12569273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of angiotensin-converting enzyme inhibition on altered renal hemodynamics induced by low protein diet in the rat.
    Fernández-Repollet E; Tapia E; Martínez-Maldonado M
    J Clin Invest; 1987 Oct; 80(4):1045-9. PubMed ID: 3308957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition.
    Kiowski W; Linder L; Kleinbloesem C; van Brummelen P; Bühler FR
    Circulation; 1992 Jan; 85(1):1-8. PubMed ID: 1728438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of the blood pressure and renal hemodynamic effects of captopril.
    Hall JE; Granger JP
    Am J Cardiol; 1982 Apr; 49(6):1527-9. PubMed ID: 7041591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of oral contraceptives on the nitric oxide system and renal function.
    Cherney DZ; Scholey JW; Cattran DC; Kang AK; Zimpelmann J; Kennedy C; Lai V; Burns KD; Miller JA
    Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1539-44. PubMed ID: 17715260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short- and long-term effects of spirapril on renal hemodynamics in patients with essential hypertension.
    Reams GP; Lau A; Knaus V; Bauer JH
    J Clin Pharmacol; 1993 Apr; 33(4):348-53. PubMed ID: 8473550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
    Azizi M; Guyene TT; Chatellier G; Ménard J
    J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sympathetic and renin-angiotensin systems contribute to increased blood pressure in sucrose-fed rats.
    Freitas RR; Lopes KL; Carillo BA; Bergamaschi CT; Carmona AK; Casarini DE; Furukawa L; Heimann JC; Campos RR; Dolnikoff MS
    Am J Hypertens; 2007 Jun; 20(6):692-8. PubMed ID: 17531930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of captopril on renal functions, renal and portal hemodynamics in patients with cirrhosis.
    Tsai YT; Lin HC; Lee FY; Hou MC; Wang SS; Lee SD
    Proc Natl Sci Counc Repub China B; 1996 Apr; 20(2):44-50. PubMed ID: 8931343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal hemodynamics in essential and renovascular hypertension. Influence of captopril.
    Hollenberg NK
    Am J Med; 1984 May; 76(5B):22-8. PubMed ID: 6328983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of an angiotensin II antagonist; [sarcosine 1, isoleucine 8] angiotensin II, on blood pressure, plasma renin activity and plasma aldosterone concentration in hypertensive and normotensive subjects taking oral contraceptives.
    Ogihara T; Hata T; Maruyama A; Nakamaru M; Mikami H; Kumahara Y
    Endocrinol Jpn; 1979 Oct; 26(5):591-7. PubMed ID: 393505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.